MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
IPHA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Innate Pharma SA (IPHA) Ownership - Who owns Innate Pharma SA?

Innate Pharma SA is a clinical-stage biotechnology company... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
117, Avenue de Luminy
Phone
+33 430303030
Employees
164
Web
https://www.innate-pharma.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
180.46M
P/E Ratio
11.15
Total Cash
10.9M
Projected Growth
N/A
Total Debt
20.21M
Revenue
4.23M
Risk (Beta)
0.93
Dividend Yield
N/A
Total Cash/Share
0.10
Total Debt/Equity
N/A
Revenue/Share
0.05 USD as % of share price
View a ticker or compare two or three
Ask AI
VS
Compare
VS
Compare
IPHA
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
View AI-Driven Trading for IPHA
A.I. Advisor
published General Information

General Information

a biopharmaceutical company, which focuses on discovering and developing therapeutic antibodies that harness the innate immune system to improve cancer treatment

Industry Biotechnology

Industry
N/A
Address
117, Avenue de Luminy
Phone
+33 430303030
Employees
164
Web
https://www.innate-pharma.com
Who owns Innate Pharma SA? IPHA symbol Ownership - Tickeron.com